Single or tandem autologous stem cell transplantation for treating Chinese patients with refractory/relapsed classical Hodgkin lymphoma.
Chen ZhangJili DengYan XieLan MiWeiping LiuXiaopei WangLinjun ZhaoYuqin SongJun ZhuPublished in: Cancer medicine (2023)
Our study discusses the advantages of tandem transplantation for high-risk patients with R/R cHL.